Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Decitabine for Poor Graft Function Post Allo-HSCT
NCT05907499Phase 3Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jul 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in poor graft function (PGF), sponsored by First Affiliated Hospital of Soochow University. Started Jul 2023; status: completed.
02
Drugs
decitabine
03
Conditions
poor graft function (PGF)
Beyond the preview
Go deeper on NCT05907499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05907499.